Conatus Pharmaceuticals Inc. (CNAT) Gains: Stock Up 8.71%

Zacks


Conatus Pharmaceuticals Inc. (CNAT) was a big mover last session, as the company saw its shares rise nearly 9% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This stock, trading in a volatile price range of $5.54 to $9.48 in the past one-month time frame, showed a pick-up yesterday at $9.11.

In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate of a loss narrowed over the same time frame suggesting that more solid trading could be ahead for Conatus Pharmaceuticals. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
    
Conatus Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Other better-ranked players in the same industry include OraSure Technologies, Inc. (OSUR), Owens & Minor Inc. (OMI) and ICU Medical, Inc. (ICUI), all carrying a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>






CONATUS PHARMACEUTICALS INC (CNAT): Free Stock Analysis Report

ICU MEDICAL INC (ICUI): Free Stock Analysis Report

ORASURE TECHNOLOGIES INC (OSUR): Free Stock Analysis Report

OWENS & MINOR INC (OMI): Free Stock Analysis Report


Zacks Investment Research

View Comments (0)